| Style | Citing Format |
|---|---|
| MLA | Rahbarnia L, et al.. "Current Trends in Targeted Therapy for Drug-Resistant Infections." Applied Microbiology and Biotechnology, vol. 103, no. 20, 2019, pp. 8301-8314. |
| APA | Rahbarnia L, Farajnia S, Naghili B, Ahmadzadeh V, Veisi K, Baghban R, Toraby S (2019). Current Trends in Targeted Therapy for Drug-Resistant Infections. Applied Microbiology and Biotechnology, 103(20), 8301-8314. |
| Chicago | Rahbarnia L, Farajnia S, Naghili B, Ahmadzadeh V, Veisi K, Baghban R, Toraby S. "Current Trends in Targeted Therapy for Drug-Resistant Infections." Applied Microbiology and Biotechnology 103, no. 20 (2019): 8301-8314. |
| Harvard | Rahbarnia L et al. (2019) 'Current Trends in Targeted Therapy for Drug-Resistant Infections', Applied Microbiology and Biotechnology, 103(20), pp. 8301-8314. |
| Vancouver | Rahbarnia L, Farajnia S, Naghili B, Ahmadzadeh V, Veisi K, Baghban R, et al.. Current Trends in Targeted Therapy for Drug-Resistant Infections. Applied Microbiology and Biotechnology. 2019;103(20):8301-8314. |
| BibTex | @article{ author = {Rahbarnia L and Farajnia S and Naghili B and Ahmadzadeh V and Veisi K and Baghban R and Toraby S}, title = {Current Trends in Targeted Therapy for Drug-Resistant Infections}, journal = {Applied Microbiology and Biotechnology}, volume = {103}, number = {20}, pages = {8301-8314}, year = {2019} } |
| RIS | TY - JOUR AU - Rahbarnia L AU - Farajnia S AU - Naghili B AU - Ahmadzadeh V AU - Veisi K AU - Baghban R AU - Toraby S TI - Current Trends in Targeted Therapy for Drug-Resistant Infections JO - Applied Microbiology and Biotechnology VL - 103 IS - 20 SP - 8301 EP - 8314 PY - 2019 ER - |